BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24517116)

  • 1. Next generation sequencing analysis of miRNAs: MiR-127-3p inhibits glioblastoma proliferation and activates TGF-β signaling by targeting SKI.
    Jiang H; Jin C; Liu J; Hua D; Zhou F; Lou X; Zhao N; Lan Q; Huang Q; Yoon JG; Zheng S; Lin B
    OMICS; 2014 Mar; 18(3):196-206. PubMed ID: 24517116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
    Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
    Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma.
    Zuo J; Yu H; Xie P; Liu W; Wang K; Ni H
    Gene; 2019 Aug; 710():233-239. PubMed ID: 31181312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
    Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
    Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCMV-encoded miR-UL112-3p promotes glioblastoma progression via tumour suppressor candidate 3.
    Liang Q; Wang K; Wang B; Cai Q
    Sci Rep; 2017 Mar; 7():44705. PubMed ID: 28303930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
    Agrawal R; Pandey P; Jha P; Dwivedi V; Sarkar C; Kulshreshtha R
    BMC Genomics; 2014 Aug; 15(1):686. PubMed ID: 25129238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
    Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma.
    Xu G; Li JY
    Tumour Biol; 2016 Aug; 37(8):10577-86. PubMed ID: 26857280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.
    Sun J; Tian X; Zhang J; Huang Y; Lin X; Chen L; Zhang S
    J Exp Clin Cancer Res; 2017 Aug; 36(1):100. PubMed ID: 28764788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-331-3p regulates expression of neuropilin-2 in glioblastoma.
    Epis MR; Giles KM; Candy PA; Webster RJ; Leedman PJ
    J Neurooncol; 2014 Jan; 116(1):67-75. PubMed ID: 24142150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221-3p/222-3p axis in glioblastoma.
    Malik N; Kundu A; Gupta Y; Irshad K; Arora M; Goswami S; Mahajan S; Sarkar C; Suri V; Suri A; Chattopadhyay P; Sinha S; Chosdol K
    Mol Carcinog; 2023 Dec; 62(12):1817-1831. PubMed ID: 37606187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells.
    Guo X; Xue H; Guo X; Gao X; Xu S; Yan S; Han X; Li T; Shen J; Li G
    Oncotarget; 2015 Dec; 6(39):41620-37. PubMed ID: 26536662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.
    Cunha PP; Costa PM; Morais CM; Lopes IR; Cardoso AM; Cardoso AL; Mano M; Jurado AS; Pedroso de Lima MC
    Hum Mol Genet; 2017 Nov; 26(22):4375-4387. PubMed ID: 28973155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Inhibition of miR-144-3p on Cell Proliferation and Metastasis by Targeting TOP2A in HCMV-Positive Glioblastoma Cells.
    Song J; Ma Q; Hu M; Qian D; Wang B; He N
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.
    Liu H; Li C; Shen C; Yin F; Wang K; Liu Y; Zheng B; Zhang W; Hou X; Chen X; Wu J; Wang X; Zhong C; Zhang J; Shi H; Ai J; Zhao S
    J Neurooncol; 2015 May; 122(3):431-9. PubMed ID: 25720694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
    Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.